Using Umbilical Cord Stem Cells to Treat Rheumatoid Arthritis
Author Information
Author(s): Liu Yanying, Mu Rong, Wang Shiyao, Long Li, Liu Xia, Li Ru, Sun Jian, Guo Jianping, Zhang Xiaoping, Guo Jing, Yu Ping, Li Chunlei, Liu Xiangyuan, Huang Zhenyu, Wang Dapeng, Li Hu, Gu Zhifeng, Liu Bing, Li Zhanguo
Primary Institution: Peking University People's Hospital
Hypothesis
Can human umbilical cord mesenchymal stem cells (UC-MSCs) effectively treat rheumatoid arthritis (RA)?
Conclusion
Human UC-MSCs can suppress inflammation and improve symptoms in rheumatoid arthritis by inhibiting certain immune responses.
Supporting Evidence
- UC-MSCs inhibited the proliferation of fibroblast-like synoviocytes from RA patients.
- Systemic infusion of UC-MSCs reduced the severity of collagen-induced arthritis in mice.
- UC-MSCs increased the levels of anti-inflammatory cytokine IL-10 in treated mice.
- UC-MSCs induced the expansion of regulatory T cells in RA patients.
- UC-MSCs suppressed the production of proinflammatory cytokines like TNF-α and IL-6.
Takeaway
Doctors are testing if special cells from umbilical cords can help people with a painful joint disease called rheumatoid arthritis by calming down the immune system.
Methodology
The study involved isolating UC-MSCs and testing their effects on fibroblast-like synoviocytes and T cells from RA patients, as well as using a mouse model of collagen-induced arthritis.
Potential Biases
Potential bias in participant selection and the small sample size of human subjects.
Limitations
The study primarily used a mouse model, which may not fully replicate human RA conditions.
Participant Demographics
5 RA patients (females, aged 30-60) and 10 RA patients (females, aged 35-56) were included.
Statistical Information
P-Value
0.000
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website